Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry

The medical use of cannabis has a very long history. Although many substances called cannabinoids are present in cannabis, Δ9tetrahydrocannabinol (Δ9-THC), cannabidiol (CBD) and cannabinol (CBN) are the three main cannabinoids that are most present and described. CBD itself is not responsible for the psychotropic effects of cannabis, since it does not produce the typical behavioral effects associated with the consumption of this drug. CBD has recently gained growing attention in modern society and seems to be increasingly explored in dentistry. Several subjective findings suggest some therapeutic effects of CBD that are strongly supported by research evidence. However, there is a plethora of data regarding CBD’s mechanism of action and therapeutic potential, which are in many cases contradictory. We will first provide an overview of the scientific evidence on the molecular mechanism of CBD’s action. Furthermore, we will map the recent developments regarding the possible oral benefits of CBD. In summary, we will highlight CBD’s promising biological features for its application in dentistry, despite exiting patents that suggest the current compositions for oral care as the main interest of the industry.

[1]  Lina Yu,et al.  Cannabidiol Rescues TNF-α-Inhibited Proliferation, Migration, and Osteogenic/Odontogenic Differentiation of Dental Pulp Stem Cells , 2023, Biomolecules.

[2]  J. Castellanos,et al.  Immune challenges upregulate the expression of cannabinoid receptors in cultured human odontoblasts and gingival fibroblasts , 2022, Acta odontologica latinoamericana : AOL.

[3]  R. Duarte,et al.  Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study , 2022, Journal of Cannabis Research.

[4]  H. Bradshaw,et al.  Cannabinoid CB1 receptors regulate salivation , 2022, Scientific Reports.

[5]  M. Azizi,et al.  Evaluation of cannabinoid receptors type 1–2 in periodontitis patients , 2022, Clinical and experimental dental research.

[6]  K. Derefinko,et al.  A critical review of cannabis in medicine and dentistry: A look back and the path forward , 2022, Clinical and experimental dental research.

[7]  J. Vacek,et al.  Cannabidiol and periodontal inflammatory disease: A critical assessment. , 2022, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[8]  A. Inchingolo,et al.  Cannabinoids Drugs and Oral Health—From Recreational Side-Effects to Medicinal Purposes: A Systematic Review , 2021, International journal of molecular sciences.

[9]  J. Arnold,et al.  Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization , 2021, The AAPS Journal.

[10]  C. Limebeer,et al.  Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting. , 2021, Cannabis and cannabinoid research.

[11]  Haipei Luan,et al.  Investigation of in vitro odonto/osteogenic capacity of cannabidiol on human dental pulp cell. , 2021, Journal of dentistry.

[12]  Laureano Schofs,et al.  The antimicrobial effect behind Cannabis sativa , 2021, Pharmacology research & perspectives.

[13]  John F. Trant,et al.  The biosynthesis of the cannabinoids , 2021, Journal of Cannabis Research.

[14]  M. Silvestrini,et al.  Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox–Gastaut Syndrome , 2021, CNS Drugs.

[15]  A. Jones,et al.  The Past, Present and Future of Cannabis sativa Tissue Culture , 2020, Plants.

[16]  S. Paurazas,et al.  Evaluation of Cannabinoids on the Odonto/osteogenesis in Human Dental Pulp Cells In Vitro. , 2020, Journal of endodontics.

[17]  I. Berindan‐Neagoe,et al.  Cannabidiol and Vitamin D3 Impact on Osteogenic Differentiation of Human Dental Mesenchymal Stem Cells , 2020, Medicina.

[18]  N. Toyang,et al.  Non-Cannabinoid Metabolites of Cannabis sativa L. with Therapeutic Potential , 2020, Plants.

[19]  Yousef N. Alharbi Current legal status of medical marijuana and cannabidiol in the United States , 2020, Epilepsy & Behavior.

[20]  M. Crocq History of cannabis and the endocannabinoid system
 , 2020, Dialogues in clinical neuroscience.

[21]  H. Clarke,et al.  Understanding the Medical Chemistry of the Cannabis Plant is Critical to Guiding Real World Clinical Evidence , 2020, Molecules.

[22]  Jayme L. Dahlin,et al.  The Essential Medicinal Chemistry of Cannabidiol (CBD). , 2020, Journal of medicinal chemistry.

[23]  S. Daunert,et al.  Cannabidiol as a Novel Therapeutic for Immune Modulation , 2020, ImmunoTargets and therapy.

[24]  Dennis J Sholler,et al.  Therapeutic Efficacy of Cannabidiol (CBD): a Review of the Evidence From Clinical Trials and Human Laboratory Studies , 2020, Current Addiction Reports.

[25]  I. Koturbash,et al.  Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway , 2020, Journal of dietary supplements.

[26]  Y. Gabet,et al.  The Cannabinoids Effect on Bone Formation and Bone Healing , 2020, Current Osteoporosis Reports.

[27]  B. Møller,et al.  Phytocannabinoids: Origins and Biosynthesis. , 2020, Trends in plant science.

[28]  T. Dick,et al.  Phytotherapy in Dentistry: A Literature Review Based on Clinical Data , 2020 .

[29]  R. Moraes,et al.  Cannabidiol in Dentistry: A Scoping Review , 2020, Dentistry journal.

[30]  F. Guimarães,et al.  Cannabidiol on 5-FU-induced oral mucositis in mice. , 2020, Oral diseases.

[31]  N. Seeram,et al.  Inhibitory Effect of Cannabidiol on the Activation of NLRP3 Inflammasome Is Associated with Its Modulation of the P2X7 Receptor in Human Monocytes. , 2020, Journal of natural products.

[32]  V. Stahl,et al.  Comparison of Efficacy of Cannabinoids versus Commercial Oral Care Products in Reducing Bacterial Content from Dental Plaque: A Preliminary Observation , 2020, Cureus.

[33]  M. Haque,et al.  Preparation of Medicinal Plants: Basic Extraction and Fractionation Procedures for Experimental Purposes , 2020, Journal of pharmacy & bioallied sciences.

[34]  S. Atalay,et al.  Antioxidative and Anti-Inflammatory Properties of Cannabidiol , 2019, Antioxidants.

[35]  Haiyan Lu,et al.  Activation of Cannabinoid Receptors Promote Periodontal Cell Adhesion and Migration. , 2019, Journal of clinical periodontology.

[36]  P. Yates,et al.  Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD) , 2019, BMC Palliative Care.

[37]  R. Lamont,et al.  Marijuana-Derived Cannabinoids Trigger a CB2/PI3K Axis of Suppression of the Innate Response to Oral Pathogens , 2019, Front. Immunol..

[38]  A. Kamali,et al.  Cannabidiol-loaded microspheres incorporated into osteoconductive scaffold enhance mesenchymal stem cell recruitment and regeneration of critical-sized bone defects. , 2019, Materials science & engineering. C, Materials for biological applications.

[39]  Debopam Samanta Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy. , 2019, Pediatric neurology.

[40]  H. Duncan,et al.  European Society of Endodontology position statement: Management of deep caries and the exposed pulp. , 2019, International endodontic journal.

[41]  M. Lefsrud,et al.  An Update on Plant Photobiology and Implications for Cannabis Production , 2019, Front. Plant Sci..

[42]  M. R. Iyer,et al.  Crystal Structure of the Human Cannabinoid Receptor CB2 , 2019, Cell.

[43]  M. Baciut,et al.  Cannabinoids and bone regeneration , 2019, Drug metabolism reviews.

[44]  R. Franco,et al.  Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1‐CB2 heteroreceptor complexes , 2018, Biochemical pharmacology.

[45]  K. Mackie,et al.  Cannabidiol's Upregulation of N-acyl Ethanolamines in the Central Nervous System Requires N-acyl Phosphatidyl Ethanolamine-Specific Phospholipase D , 2018, Cannabis and cannabinoid research.

[46]  P. Ruben,et al.  Inhibitory effects of cannabidiol on voltage-dependent sodium currents , 2018, The Journal of Biological Chemistry.

[47]  M. Alaverdashvili,et al.  Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors , 2018, British journal of pharmacology.

[48]  F. Guimarães,et al.  Effects of cannabidiol, a Cannabis sativa constituent, on oral wound healing process in rats: Clinical and histological evaluation , 2018, Phytotherapy research : PTR.

[49]  E. Mazzon,et al.  Treatment of Periodontal Ligament Stem Cells with MOR and CBD Promotes Cell Survival and Neuronal Differentiation via the PI3K/Akt/mTOR Pathway , 2018, International journal of molecular sciences.

[50]  E. Ovidi,et al.  Natural products for human health: an historical overview of the drug discovery approaches , 2018, Natural product research.

[51]  B. Malinowska,et al.  Enhanced endocannabinoid tone as a potential target of pharmacotherapy , 2018, Life sciences.

[52]  Z. Song,et al.  GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol , 2018, Acta Pharmacologica Sinica.

[53]  M. Maranesi,et al.  The presence and distribution of cannabinoid type 1 and 2 receptors in the mandibular gland: The influence of different physical forms of diets on their expression in piglets , 2018, Journal of animal physiology and animal nutrition.

[54]  N. Teixeira,et al.  Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis , 2018, Journal of Physiology and Biochemistry.

[55]  Julen Oyarzabal,et al.  Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors , 2017, Front. Pharmacol..

[56]  H. Kondo,et al.  Immunohistochemical localization of cannabinoid receptor 1 (CB1) in the submandibular gland of mice under normal conditions and when stimulated by isoproterenol or carbachol. , 2017, Archives of oral biology.

[57]  A. Malfitano,et al.  Cannabidiol: State of the art and new challenges for therapeutic applications. , 2017, Pharmacology & therapeutics.

[58]  F. Grotenhermen,et al.  An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies , 2017, Cannabis and cannabinoid research.

[59]  I. McGregor,et al.  The direct actions of cannabidiol and 2‐arachidonoyl glycerol at GABAA receptors , 2017, Pharmacological research.

[60]  M. L. de la Casa,et al.  Evaluation of pH and calcium ion diffusion from calcium hydroxide pastes and MTA. , 2017, Acta odontologica latinoamericana : AOL.

[61]  P. Brossart,et al.  In vivo and In vitro Identification of Endocannabinoid Signaling in Periodontal Tissues and Their Potential Role in Local Pathophysiology , 2017, Cellular and Molecular Neurobiology.

[62]  E. Piva,et al.  Could the application of bioactive molecules improve vital pulp therapy success? A systematic review. , 2017, Journal of biomedical materials research. Part A.

[63]  M. Bifulco,et al.  Modern History of Medical Cannabis: From Widespread Use to Prohibitionism and Back. , 2017, Trends in pharmacological sciences.

[64]  M. A. Figueiredo,et al.  Cannabidiol: an alternative therapeutic agent for oral mucositis? , 2017, Journal of clinical pharmacy and therapeutics.

[65]  F. Wang,et al.  Expression of Cannabinoid Type 1 Receptors in Human Odontoblast Cells , 2017, Journal of endodontics.

[66]  E. Mazzon,et al.  Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells , 2016, Front. Physiol..

[67]  J. Cherney,et al.  Industrial Hemp in North America: Production, Politics and Potential , 2016 .

[68]  R. Stevens,et al.  Crystal Structure of the Human Cannabinoid Receptor CB1 , 2016, Cell.

[69]  M. Ashley,et al.  Cannabis: A joint problem for patients and the dental profession , 2016, BDJ.

[70]  J. Elverdín,et al.  Anti-Inflammatory and Osteoprotective Effects of Cannabinoid-2 Receptor Agonist HU-308 in a Rat Model of Lipopolysaccharide-Induced Periodontitis. , 2016, Journal of periodontology.

[71]  J. Klijanienko,et al.  Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients’ survival , 2016, Tumor Biology.

[72]  M. Nagarkatti,et al.  Critical Role of Mast Cells and Peroxisome Proliferator–Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo , 2015, The Journal of Immunology.

[73]  Joseph M Pappachan,et al.  Diabetes mellitus and oral health , 2015, Endocrine.

[74]  S. Burstein Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. , 2015, Bioorganic & medicinal chemistry.

[75]  D. Deutsch,et al.  Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)* , 2015, The Journal of Biological Chemistry.

[76]  V. Marzo,et al.  Endocannabinoid signalling and the deteriorating brain , 2014, Nature Reviews Neuroscience.

[77]  Namrata Singh,et al.  Cannabinoid-induced changes in respiration of brain mitochondria. , 2014, Toxicology letters.

[78]  C. Fowler,et al.  Cannabidiol Improves Vasorelaxation in Zucker Diabetic Fatty Rats through Cyclooxygenase Activation , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[79]  R. Mechoulam,et al.  Early phytocannabinoid chemistry to endocannabinoids and beyond , 2014, Nature Reviews Neuroscience.

[80]  E. Murillo-Rodríguez,et al.  Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats , 2014, Neuroscience Research.

[81]  A. Padovani,et al.  Epithelial expression of vanilloid and cannabinoid receptors: a potential role in burning mouth syndrome pathogenesis. , 2014, Histology and histopathology.

[82]  R. Ramer,et al.  Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK. , 2014, Biochemical pharmacology.

[83]  Z. Vogel,et al.  Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death , 2013, Cell Death and Disease.

[84]  B. Sadek,et al.  Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors. , 2013, European journal of pharmacology.

[85]  L. Mestre,et al.  Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors , 2013, Neurobiology of Disease.

[86]  D. Geschwind,et al.  Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells , 2013, PloS one.

[87]  M. Elphick The evolution and comparative neurobiology of endocannabinoid signalling , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[88]  Y. Sahara,et al.  TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts. , 2012, Cell calcium.

[89]  Joshua R. Smith,et al.  Harnessing the natural regenerative potential of the dental pulp. , 2012, Dental clinics of North America.

[90]  D. Tipton,et al.  Effect of cannabidiol on human gingival fibroblast extracellular matrix metabolism: MMP production and activity, and production of fibronectin and transforming growth factor β. , 2012, Journal of periodontal research.

[91]  M. Torii,et al.  Anandamide induces matrix metalloproteinase-2 production through cannabinoid-1 receptor and transient receptor potential vanilloid-1 in human dental pulp cells in culture. , 2012, Journal of endodontics.

[92]  P. Fletcher,et al.  Cannabidiol, a non‐psychotropic component of cannabis, attenuates vomiting and nausea‐like behaviour via indirect agonism of 5‐HT1A somatodendritic autoreceptors in the dorsal raphe nucleus , 2012, British journal of pharmacology.

[93]  L. Ford,et al.  Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro , 2012, British journal of pharmacology.

[94]  M. Hellmich,et al.  Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia , 2012, Translational Psychiatry.

[95]  T. Bisogno,et al.  Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes , 2011, British journal of pharmacology.

[96]  M. Borges,et al.  Oral and maxillofacial trauma in patients with epilepsy: prospective study based on an outpatient population. , 2011, Arquivos de neuro-psiquiatria.

[97]  P. Anand,et al.  Cannabinoid receptor CB1-immunoreactive nerve fibres in painful and non-painful human tooth pulp , 2010, Journal of Clinical Neuroscience.

[98]  M. Maccarrone,et al.  GPR55: Current knowledge and future perspectives of a purported "Type-3" cannabinoid receptor. , 2010, Current medicinal chemistry.

[99]  T. Shippenberg,et al.  The Nonpsychoactive Cannabinoid Cannabidiol Inhibits 5-Hydroxytryptamine3A Receptor-Mediated Currents in Xenopus laevis Oocytes , 2010, Journal of Pharmacology and Experimental Therapeutics.

[100]  I. Maruyama,et al.  Involvement of the endocannabinoid system in periodontal healing. , 2010, Biochemical and biophysical research communications.

[101]  R. Margolskee,et al.  Endocannabinoids selectively enhance sweet taste , 2009, Proceedings of the National Academy of Sciences.

[102]  Z. Vogel,et al.  Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells* , 2009, The Journal of Biological Chemistry.

[103]  Wayne Hall,et al.  Adverse health effects of non-medical cannabis use , 2009, The Lancet.

[104]  K. Mackie,et al.  The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo , 2009, Proceedings of the National Academy of Sciences.

[105]  V. Rettori,et al.  Role of the endocannabinoid system in ethanol-induced inhibition of salivary secretion. , 2009, Alcohol and alcoholism.

[106]  G. Godlewski,et al.  Receptors for acylethanolamides-GPR55 and GPR119. , 2009, Prostaglandins & other lipid mediators.

[107]  I. Yamamoto,et al.  Cannabidiol-2′,6′-Dimethyl Ether, a Cannabidiol Derivative, Is a Highly Potent and Selective 15-Lipoxygenase Inhibitor , 2009, Drug Metabolism and Disposition.

[108]  D. Fuchs,et al.  Δ9-Tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro , 2009, Journal of Neuroimmunology.

[109]  M. Karst,et al.  The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function , 2009, Pharmacology.

[110]  F. Guimarães,et al.  Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. , 2009, International immunopharmacology.

[111]  M. Holland,et al.  Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). , 2008, European journal of pharmacology.

[112]  V. Marzo The endocannabinoid system in obesity and type 2 diabetes , 2008, Diabetologia.

[113]  T. Hutchinson,et al.  TRPV2 Is Activated by Cannabidiol and Mediates CGRP Release in Cultured Rat Dorsal Root Ganglion Neurons , 2008, The Journal of Neuroscience.

[114]  M. Connor,et al.  Inhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and Cannabidiol* , 2008, Journal of Biological Chemistry.

[115]  V. Vellani,et al.  Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8 , 2008, Journal of Pharmacology and Experimental Therapeutics.

[116]  C. Reynet,et al.  GPR119, a novel G protein‐coupled receptor target for the treatment of type 2 diabetes and obesity , 2008, British journal of pharmacology.

[117]  K. Mackie,et al.  GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current , 2008, Proceedings of the National Academy of Sciences.

[118]  S. Hjorth,et al.  The orphan receptor GPR55 is a novel cannabinoid receptor , 2007, British journal of pharmacology.

[119]  Ethan B. Russo History of Cannabis and Its Preparations in Saga, Science, and Sobriquet , 2007, Chemistry & biodiversity.

[120]  Didier Bagnol,et al.  A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. , 2007, Endocrinology.

[121]  R. Pertwee,et al.  Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro , 2007, British journal of pharmacology.

[122]  P. Pacher,et al.  The Endocannabinoid System as an Emerging Target of Pharmacotherapy , 2006, Pharmacological Reviews.

[123]  S. Mccann,et al.  Inhibition of Salivary Secretion by Activation of Cannabinoid Receptors , 2006, Experimental biology and medicine.

[124]  H. Korf,et al.  Cannabinoids attenuate norepinephrine‐induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N‐acetyltransferase activity without involvement of cannabinoid receptors , 2006, Journal of neurochemistry.

[125]  C. Hillard,et al.  Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[126]  Y. Izumi,et al.  Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF‐κB pathway inhibition , 2006, FEBS letters.

[127]  M. Zeira,et al.  Cannabidiol lowers incidence of diabetes in non-obese diabetic mice , 2006, Autoimmunity.

[128]  E. Russo,et al.  Agonistic Properties of Cannabidiol at 5-HT1a Receptors , 2005, Neurochemical Research.

[129]  K. Naruse,et al.  Stretch-induced cell proliferation is mediated by FAK-MAPK pathway. , 2005, Life sciences.

[130]  I. Yamamoto,et al.  Marijuana extracts possess the effects like the endocrine disrupting chemicals. , 2005, Toxicology.

[131]  B. Costa,et al.  Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation , 2004, British journal of pharmacology.

[132]  K. Rosenblatt,et al.  Marijuana Use and Risk of Oral Squamous Cell Carcinoma , 2004, Cancer Research.

[133]  D. Piomelli The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.

[134]  A. Finazzi-Agro’,et al.  The Endocannabinoid System in Human Keratinocytes , 2003, Journal of Biological Chemistry.

[135]  M. Herkenham,et al.  International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.

[136]  D. Ponde,et al.  Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide , 2001, British journal of pharmacology.

[137]  R. Mechoulam,et al.  A historical overview of chemical research on cannabinoids. , 2000, Chemistry and physics of lipids.

[138]  M. Feldmann,et al.  The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[139]  L. Petrocellis,et al.  Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action , 1998, Trends in Neurosciences.

[140]  K. Mackie,et al.  Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. , 1995, Molecular pharmacology.

[141]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[142]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[143]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[144]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[145]  A. Howlett,et al.  Determination and characterization of a cannabinoid receptor in rat brain. , 1988, Molecular pharmacology.

[146]  F. Evans,et al.  Activation of phospholipase A2 by cannabinoids , 1987, FEBS letters.

[147]  A. Howlett,et al.  Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. , 1984, Molecular pharmacology.

[148]  R. Branconnier,et al.  Cannabis: effects on memory and the cholinergic limbic system. , 1983, Psychological bulletin.

[149]  S. R. Gilman,et al.  Cannabinoids Impair the Formation of Cholesteryl Ester in Cultured Human Cells , 1981, Arteriosclerosis.

[150]  G. Sharma,et al.  Constituents of Cannabis sativa , 1979 .

[151]  R. Pertwee,et al.  EFFECTS OF Δ9‐TETRAHYDROCANNABINOL AND CANNABIDIOL ON A Mg2+‐ATPase OF SYNAPTIC VESICLES PREPARED FROM RAT CEREBRAL CORTEX , 1977 .

[152]  F. Bazzaz,et al.  Photosynthesis and cannabinoid content of temperate and tropical populations of Cannabis sativa , 1975 .

[153]  E. R. Garrett,et al.  Physicochemical Properties, Solubility, and Protein Binding of Δ9 -Tetrahydrocannabinol , 1974 .

[154]  R. Mechoulam,et al.  Chemical Basis of Hashish Activity , 1970, Science.

[155]  R. Mechoulam,et al.  Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .

[156]  R. Adams Marihuana: Harvey Lecture, February 19, 1942. , 1942, Bulletin of the New York Academy of Medicine.

[157]  V. Stahl Cannabis and derivatives thereof for the treatment of pain and inflammation related with dental pulp and bone regeneration related to dental jaw bone defects , 2018 .

[158]  A. Howlett,et al.  CB1 and CB2 Receptor Pharmacology. , 2017, Advances in pharmacology.

[159]  G. Santoni,et al.  Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. , 2013, Carcinogenesis.

[160]  B. Klingeren,et al.  Antibacterial activity of Δ9-tetrahydrocannabinol and cannabidiol , 2004, Antonie van Leeuwenhoek.

[161]  R. Adams,et al.  Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp. I , 1940 .